Puma Biotechnology Inc (PBYI)
4.86
-0.10
(-2.02%)
USD |
NASDAQ |
May 03, 16:00
4.875
+0.02
(+0.31%)
After-Hours: 20:00
Puma Biotechnology Total Assets (Quarterly): 230.53M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 230.53M |
| September 30, 2023 | 203.60M |
| June 30, 2023 | 200.49M |
| March 31, 2023 | 196.26M |
| December 31, 2022 | 222.06M |
| September 30, 2022 | 198.77M |
| June 30, 2022 | 193.65M |
| March 31, 2022 | 200.68M |
| December 31, 2021 | 226.58M |
| September 30, 2021 | 226.29M |
| June 30, 2021 | 260.00M |
| March 31, 2021 | 258.66M |
| December 31, 2020 | 244.22M |
| September 30, 2020 | 261.70M |
| June 30, 2020 | 263.81M |
| March 31, 2020 | 225.53M |
| December 31, 2019 | 234.90M |
| September 30, 2019 | 232.04M |
| June 30, 2019 | 239.86M |
| March 31, 2019 | 331.36M |
| December 31, 2018 | 259.12M |
| September 30, 2018 | 230.72M |
| June 30, 2018 | 227.62M |
| March 31, 2018 | 169.64M |
| December 31, 2017 | 165.52M |
| Date | Value |
|---|---|
| September 30, 2017 | 181.86M |
| June 30, 2017 | 172.82M |
| March 31, 2017 | 216.62M |
| December 31, 2016 | 252.79M |
| September 30, 2016 | 134.03M |
| June 30, 2016 | 170.89M |
| March 31, 2016 | 205.17M |
| December 31, 2015 | 239.84M |
| September 30, 2015 | 271.62M |
| June 30, 2015 | 302.36M |
| March 31, 2015 | 331.88M |
| December 31, 2014 | 162.76M |
| September 30, 2014 | 172.05M |
| June 30, 2014 | 196.08M |
| March 31, 2014 | 220.25M |
| December 31, 2013 | 104.37M |
| September 30, 2013 | 115.11M |
| June 30, 2013 | 127.98M |
| March 31, 2013 | 141.02M |
| December 31, 2012 | 151.70M |
| September 30, 2012 | 36.50M |
| June 30, 2012 | 44.44M |
| March 31, 2012 | 52.82M |
| December 31, 2011 | 55.40M |
| September 30, 2011 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
193.65M
Minimum
Jun 2022
263.81M
Maximum
Jun 2020
227.35M
Average
226.58M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| ADMA Biologics Inc | 329.18M |
| Pfizer Inc | 226.50B |
| Sarepta Therapeutics Inc | 3.224B |
| Immunogen Inc (DELISTED) | 822.10M |
| United Therapeutics Corp | 6.495B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 177.09M |
| Shareholders Equity (Quarterly) | 53.44M |
| Debt to Equity Ratio | 1.865 |
| Current Ratio | 1.572 |
| Net Debt Paydown Yield | -0.16% |